OLIVA, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1263
EU - Europa 878
AS - Asia 693
OC - Oceania 43
SA - Sud America 36
AF - Africa 25
Totale 2938
Nazione #
US - Stati Uniti d'America 1224
IT - Italia 331
CN - Cina 311
DE - Germania 163
JP - Giappone 130
GB - Regno Unito 100
IN - India 54
VN - Vietnam 38
KR - Corea 35
AU - Australia 34
NL - Olanda 33
CA - Canada 31
ES - Italia 29
FR - Francia 25
RU - Federazione Russa 24
PL - Polonia 23
CZ - Repubblica Ceca 21
CH - Svizzera 20
SA - Arabia Saudita 20
ZA - Sudafrica 18
BE - Belgio 17
DK - Danimarca 17
TR - Turchia 16
ID - Indonesia 15
HK - Hong Kong 13
CO - Colombia 12
BR - Brasile 11
SE - Svezia 11
TW - Taiwan 11
GR - Grecia 10
IE - Irlanda 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
MX - Messico 7
PK - Pakistan 7
AT - Austria 6
CL - Cile 6
FI - Finlandia 6
KW - Kuwait 6
PT - Portogallo 6
SG - Singapore 6
SK - Slovacchia (Repubblica Slovacca) 6
AR - Argentina 4
HU - Ungheria 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
MO - Macao, regione amministrativa speciale della Cina 3
PH - Filippine 3
UA - Ucraina 3
AL - Albania 2
IQ - Iraq 2
MY - Malesia 2
NO - Norvegia 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
Totale 2938
Città #
Fairfield 127
Woodbridge 73
Houston 70
Torino 64
Santa Cruz 62
Seattle 61
Ashburn 57
Buffalo 57
Cambridge 49
Tokyo 49
Beijing 47
Wilmington 43
Ann Arbor 34
Wuhan 29
Dong Ket 27
Zhengzhou 25
Nanjing 24
Turin 24
Riyadh 19
Shanghai 19
Duncan 18
Fleming Island 18
Pinerolo 16
Hangzhou 15
Los Angeles 15
Rome 15
Loma Linda 14
Muizenberg 13
Clearwater 12
Jakarta 12
Raritan 12
New York 11
Chicago 10
Guangzhou 10
London 10
Mountain View 10
Changsha 9
Milan 9
Nürnberg 9
Baotou 8
Chennai 8
Milpitas 8
Rochester 8
Taipei 8
Chengdu 7
Dublin 7
Islamabad 7
Ontario 7
Ottawa 7
Portland 7
Saitama 7
Tianjin 7
Warsaw 7
Central District 6
Dallas 6
Frankfurt Am Main 6
Iowa City 6
Las Vegas 6
Leawood 6
Pisa 6
San Diego 6
Sydney 6
Bengaluru 5
Boardman 5
Bratislava 5
Bremen 5
Brisbane 5
Changchun 5
Durham 5
Helsinki 5
Lake Forest 5
Lanzhou 5
Oxford 5
Padova 5
Santiago 5
Seoul 5
University Park 5
Vienna 5
Anzola Dell'emilia 4
Athens 4
Berlin 4
Bern 4
Bologna 4
Brussels 4
Budapest 4
Buenos Aires 4
Charlottesville 4
Clayton 4
Florence 4
Flushing 4
Fuzhou 4
Gurgaon 4
Hamilton 4
Hyderabad 4
Melbourne 4
Montréal 4
Munich 4
Nashville 4
New Haven 4
Odense 4
Totale 1523
Nome #
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial, file e27ce428-2810-2581-e053-d805fe0acbaa 1285
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma, file e27ce42a-e94a-2581-e053-d805fe0acbaa 525
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results, file e27ce427-86ab-2581-e053-d805fe0acbaa 190
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group, file e27ce42f-8b46-2581-e053-d805fe0acbaa 123
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma, file e27ce42f-76fc-2581-e053-d805fe0acbaa 115
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives, file e27ce42c-54ed-2581-e053-d805fe0acbaa 100
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents, file e27ce430-bd95-2581-e053-d805fe0acbaa 91
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma, file e27ce42f-55dd-2581-e053-d805fe0acbaa 90
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis, file e27ce42f-6e99-2581-e053-d805fe0acbaa 90
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies, file e27ce42f-55d7-2581-e053-d805fe0acbaa 84
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial, file e27ce431-d84e-2581-e053-d805fe0acbaa 64
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives, file e27ce430-e584-2581-e053-d805fe0acbaa 56
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis, file e27ce433-b2d9-2581-e053-d805fe0acbaa 51
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino, file e27ce42e-70fd-2581-e053-d805fe0acbaa 39
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 489a1238-a926-41d6-a0aa-7120055380bb 16
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials, file e27ce432-a7ee-2581-e053-d805fe0acbaa 15
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives, file e27ce42f-74db-2581-e053-d805fe0acbaa 14
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing, file e27ce435-6515-2581-e053-d805fe0acbaa 14
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma, file e27ce434-bceb-2581-e053-d805fe0acbaa 13
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing, file a4e97a93-3d82-4aaa-b92d-85fef843542e 12
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis, file e27ce435-4480-2581-e053-d805fe0acbaa 10
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives, file e27ce430-e585-2581-e053-d805fe0acbaa 7
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing, file e27ce431-1142-2581-e053-d805fe0acbaa 7
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis, file e27ce42f-a041-2581-e053-d805fe0acbaa 5
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate, file e27ce42f-f8a5-2581-e053-d805fe0acbaa 5
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file e27ce431-17eb-2581-e053-d805fe0acbaa 4
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file e27ce435-602e-2581-e053-d805fe0acbaa 4
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 5c9d2b60-09e0-49eb-9c2c-ee2f867045f5 2
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study., file bd0c03a0-25ee-4e5f-b8e8-a56c001551f7 2
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis, file e27ce435-47c3-2581-e053-d805fe0acbaa 2
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients., file e27ce435-7965-2581-e053-d805fe0acbaa 2
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 0535c2ac-4a44-4200-b69d-f7ea162511a0 1
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study., file 76132f37-39f2-4e02-9047-0432fca0b928 1
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma, file 83fd1b50-5e9e-43f2-b97b-386e3da945b1 1
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set, file e27ce431-0d6e-2581-e053-d805fe0acbaa 1
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results, file e27ce431-127a-2581-e053-d805fe0acbaa 1
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, file e27ce431-12e4-2581-e053-d805fe0acbaa 1
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial, file e27ce432-443a-2581-e053-d805fe0acbaa 1
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma, file e27ce432-d1f9-2581-e053-d805fe0acbaa 1
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?, file e27ce432-d349-2581-e053-d805fe0acbaa 1
Totale 3046
Categoria #
all - tutte 3596
article - articoli 0
book - libri 0
conference - conferenze 61
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201813 0000 00 00 00013
2018/2019389 31334926 1911 2624 44365337
2019/2020522 39283847 5235 4429 81414741
2020/2021768 53514055 9777 7289 37576179
2021/2022641 79404368 4322 5556 32389867
2022/2023399 20378059 2228 3545 1924291
Totale 3046